BioGend Therapeutics Co., Ltd. (TPEX:6733)
24.95
-0.15 (-0.60%)
Sep 30, 2026, 1:30 PM CST
| Market Cap | 3.37B -32.5% |
| Revenue (ttm) | 236.58M +21.3% |
| Net Income | -67.84M |
| EPS | -0.54 |
| Shares Out | 134.32M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 98,720 |
| Open | 25.20 |
| Previous Close | 25.10 |
| Day's Range | 24.85 - 25.30 |
| 52-Week Range | 23.45 - 46.75 |
| Beta | 0.08 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 9, 2026 |